Comparative efficacy of zanubrutinib (ZANU) versus fixed-duration acalabrutinib plus venetoclax (AV) for first-line treatment of chronic lymphocytic leukemia (CLL): A matching-adjusted indirect comparison (MAIC)
Loading...
All Authors
LTHT Author
LTHT Department
Contributor Profession (Non Medical)
Publication Date
Item Type
Article
Language
Subject
Subject Headings
Journal Title
Journal ISSN
Volume Title
Abstract
Journal
Journal of Clinical Oncology